Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 3/2019

01-03-2019 | Annotated Sequence Record

Complete genome sequence of a novel bacteriophage, PBKP05, infecting Klebsiella pneumoniae

Authors: Hyun Keun Oh, Kyoungeun Cha, Yoon Jung Hwang, Jaehak Cho, Yunyeol Jo, Heejoon Myung

Published in: Archives of Virology | Issue 3/2019

Login to get access

Abstract

An increasing number of Klebsiella pneumoniae isolates have been found to be multi-drug resistant. A novel bacteriophage, PBKP05, which infects K. pneumoniae, was isolated and characterized. It has a linear double-stranded DNA genome of 30,240 base pairs in length. Its G+C content is 53%, and 47 putative open reading frames are functionally annotated. This phage can be a candidate material for phage therapy.
Appendix
Available only for authorised users
Literature
1.
Wyres KL, Holt KE (2018) Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol 45:131–139CrossRefPubMed
2.
Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 11:297–308CrossRefPubMed
3.
Navon-Venezia S, Kondratyeva K, Carattoli A (2017) Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 41:252–275CrossRefPubMed
4.
Rozwandowicz M, Brouwer MSM, Fischer J et al (2018) Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother 73(5):1121–1137CrossRefPubMed
5.
Fritzenwanker M, Imirzalioglu C, Herold S et al (2018) Treatment options for carbapenem- resistant Gram-negative infections. Dtsch Arztebl Int 115(20–21):345–352PubMedPubMedCentral
6.
Krapp F, Ozer EA, Qi C et al (2018) Case report of an extensively drug-resistant Klebsiella pneumoniae infection with genomic characterization of the strain and review of similar cases in the United States. Open Forum Infect Dis 5(5):ofy074CrossRefPubMedPubMedCentral
7.
Chong Y, Shimoda S, Shimono N (2018) Current epidemiology, genetic evolution and clinical impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol 61:185–188CrossRef
8.
Domingo-Calap P, Delgado-Martínez J (2018) Bacteriophages: protagonists of a post-antibiotic era. Antibiotics (Basel) 7(3):E66CrossRef
9.
Cha K, Oh HK, Jang JY, Jo Y, Kim WK, Ha GU, Ko KS, Myung H (2018) Characterization of two novel bacteriophages infecting multidrug-resistant (MDR) Acinetobacter baumannii and evaluation of their therapeutic efficacy in vivo. Front Microbiol 9:696CrossRefPubMedPubMedCentral
10.
São-José C (2018) Engineering of phage-derived lytic enzymes: improving their potential as antimicrobials. Antibiotics (Basel) 7(2):E29CrossRef
11.
Maciejewska B, Olszak T, Drulis-Kawa Z (2018) Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application? Appl Microbiol Biotechnol 102(6):2563–2581CrossRefPubMedPubMedCentral
12.
Gelman D, Eisenkraft A, Chanishvili N et al (2018) The history and promising future of phage therapy in the military service. J Trauma Acute Care Surg 85(1S Suppl 2):S18–S26PubMed
13.
Pallavali RR, Degati VL, Lomada D et al (2017) Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS One 12(7):e0179245CrossRefPubMedPubMedCentral
14.
Chadha P, Katare OP, Chhibber S (2017) Liposome loaded phage cocktail: enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections. Burns 43(7):1532–1543CrossRefPubMed
15.
Aleshkin AV, Ershova ON, Volozhantsev NV et al (2016) Phagebiotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage 6(4):e1251379CrossRefPubMedPubMedCentral
16.
Chadha P, Katare OP, Chhibber S (2016) In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice. Microb Pathog 99:68–77CrossRefPubMed
17.
Mattila S, Ruotsalainen P, Jalasvuori M (2015) On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy. Front Microbiol 6:1271CrossRefPubMedPubMedCentral
18.
Cao F, Wang X, Wang L et al (2015) Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int 2015:752930PubMedPubMedCentral
19.
Hong SS, Jeong J, Lee J, Kim S, Min W, Myung H (2013) Therapeutic effects of bacteriophages against Salmonella gallinarum infection in chickens. J Microbiol Biotechnol 23:1478–1483CrossRefPubMed
20.
21.
Manfioletti G, Schneider C (1988) A new and fast method for preparing high quality lambda DNA suitable for sequencing. Nucleic Acids Res 16:2873–2884CrossRefPubMedPubMedCentral
22.
Gao S, Linden SB, Nelson DC (2017) Complete genome sequence of Klebsiella pneumoniae phages SopranoGao, MezzoGao, and AltoGao. Genome Announc 5(45):e01009-17CrossRefPubMedPubMedCentral
23.
Born Y, Fieseler L, Marazzi J, Lurz R, Duffy B, Loessner MJ (2011) Novel virulent and broad-host-range Erwinia amylovora bacteriophages reveal a high degree of mosaicism and a relationship to Enterobacteriaceae phages. Appl Environ Microbiol 77(17):5945–5954CrossRefPubMedPubMedCentral
Metadata
Title
Complete genome sequence of a novel bacteriophage, PBKP05, infecting Klebsiella pneumoniae
Authors
Hyun Keun Oh
Kyoungeun Cha
Yoon Jung Hwang
Jaehak Cho
Yunyeol Jo
Heejoon Myung
Publication date
01-03-2019
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2019
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-04121-9

Other articles of this Issue 3/2019

Archives of Virology 3/2019 Go to the issue

Original Article

Chilo iridescent virus encodes two functional metalloproteases

Original Article

Development of a sensitive and reliable reverse transcription droplet digital PCR assay for the detection of citrus yellow vein clearing virus

Annotated Sequence Record

Escherichia coli bacteriophage Gostya9, representing a new species within the genus T5virus

Original Article

Proteomic analysis of monkey kidney LLC-MK2 cells infected with a Thai strain Zika virus

Original Article

Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens

Original Article

Molecular dynamics of koala retrovirus infection in captive koalas in Japan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits